Luteinizing hormone response to controlled-release deslorelin in estradiol benzoate primed ovariectomized gilts

Document Type


Publication Date



Development of a controlled release formulation of gonadotropin releasing hormone that would stimulate a LH surge capable of reducing the time span of ovulations would greatly benefit reproductive management because a single timed insemination could be used. A dose-response study was conducted to determine if Deslorelin, a potent gonadotropin releasing hormone analogue, delivered via the SABER system, a biodegradable controlled release system, would stimulate an ovulatory-like LH surge in the pig. Twenty ovariectomized gilts, approximately 200 d old and 100 kg body weight (BW), received estradiol benzoate (15 μg/kg BW im) and 48 h later, the gilts were given deslorelin at 0, 12.5, 25.0, 50.0 or 100.0 μg im (n = 4 each treatment group). Compared to controls, mean blood deslorelin concentrations were still elevated at 30 h after deslorelin. Mean deslorelin magnitude, area under the curve and duration were sequentially greater (P < 0.05) in a dose-dependent sequence. Compared to controls, serum LH concentrations were elevated (P < 0.05) for 6 to 12 h after deslorelin. A dose-response relationship was absent for all parameters of LH secretion. Magnitude of the serum LH response was greatest (P < 0.05) in the 12.5 μg and 50.0 μg groups, whereas area under the curve was lower (P < 0.05) after 25.0 μg of deslorelin than after 12.5, 50.0 and 100.0 μg, which were not different from each other. Thus, no more than 12.5 μg of deslorelin is necessary to obtain maximum LH release in the model studied and doses less than 12.5 μg may also be effective.

Publication Source (Journal or Book title)


First Page


Last Page


This document is currently not available here.